DIX, Daniel, B.,GRAHAM, Kenneth, S.,KAMEN, Douglas, E.,WALSH, Scott, M.
申请号：
TN2012000342
公开号：
TN2012000342A1
申请日:
2012.06.29
申请国别(地区):
TN
年份:
2013
代理人:
摘要：
The present invention provides pharmaceutical formulations comprising a human antibody that specifically binds to human interleukin-6 receptor (hlL-6R). The formulations may contain, in addition to an anti-hlL-6R antibody, at least one amino acid, at least one sugar, and/or at least one non-ionic surfactant. The pharmaceutical formulations of the present invention exhibit a substantial degree of antibody stability after storage for several months.
